孕期戒烟激励试验(CPIT):III期随机对照试验研究方案
CPIT III是一项在苏格兰、英格兰和北爱尔兰开展的实用型多中心、平行组、个体随机对照优效性试验,计划纳入940名怀孕24周以内、年龄大于16岁的吸烟孕妇,比较在常规戒烟服务支持基础上提供最高400英镑财务代金券激励与仅常规支持对孕期戒烟的效果,主要结局为孕晚期可替宁/新烟草碱验证的戒烟状态。
要点
- 纳入940名孕24周以内、年龄大于16岁的吸烟孕妇,随机分组比较财务激励加常规戒烟服务与仅常规服务。
- 主要结局为孕晚期可替宁/新烟草碱验证的戒烟,次要结局包括戒烟服务参与度、产后6个月戒烟率及出生体重。
- 按意向性治疗分析,并进行成本效果评价和过程评价,以评估激励措施的可接受性、有效性和可推广性。
核心结论
- 该III期试验旨在确定在常规戒烟服务基础上提供最高400英镑财务激励能否有效帮助孕妇戒烟,并评估其成本效果和可接受性。
研究设计与样本
- 实用型、42个月、多中心、平行组、个体随机对照优效性试验,计划纳入940名怀孕小于24周、年龄大于16岁、英语沟通的吸烟孕妇。
- 参与者通过电话知情同意,并愿意在孕晚期和产后6个月接受随访。
- 试验在英国苏格兰、英格兰和北爱尔兰开展,参与站点覆盖多样化的戒烟服务和人群。
主要发现
- 原文未报告试验结果,仅描述研究方案。
关键数值与推荐
- 主要结局为孕晚期可替宁/新烟草碱验证的戒烟状态。
- 次要结局包括戒烟服务参与度、自约定戒烟日起4周戒烟率、产后6个月戒烟率及出生体重。
- 干预组在常规戒烟服务支持基础上获得最高400英镑的财务代金券激励,对照组仅接受常规支持。
临床怎么用
- 若试验证明激励措施可接受且具有成本效果,则可能支持将财务激励推广至英国大多数戒烟服务以帮助孕妇戒烟。
- 过程评价将识别改善招募和未来实施的机会,并探讨不同地区实施激励措施的促进和障碍因素。
局限性
- 原文为研究方案,尚未报告试验结果,因此无法评估激励措施的实际有效性和成本效果。
- 试验仅纳入英语沟通的孕妇,可能限制结果对其他语言人群的推广性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eighty per cent of UK women have at least one baby, making pregnancy an opportunity to help women stop smoking before their health is irreparably compromised. Smoking cessation during pregnancy helps protect infants from miscarriage, still birth, low birth weight, asthma, attention deficit disorder and adult cardiovascular disease. UK national guidelines highlight lack of evidence for effectiveness of financial incentives to help pregnant smokers quit. This includes a research recommendation: within a UK context, are incentives an acceptable, effective and cost-effective way to help pregnant women who smoke to quit? METHODS: The Cessation in Pregnancy Incentives Trial (CPIT) III is a pragmatic, 42-month, multi-centre, parallel-group, individually randomised controlled superiority trial of the effect on smoking status of adding to usual Stop Smoking Services (SSS) support, the offer of up to £400 of financial voucher incentives, compared with usual support alone, to quit smoking during pregnancy. Participants (n = 940) are pregnant smokers (age > 16 years, < 24 weeks pregnant, English speaking), who consent via telephone to take part and are willing to be followed-up in late pregnancy and 6 months after birth. The primary outcome is cotinine/anabasine-validated abstinence from smoking in late pregnancy. Secondary outcomes include engagement with SSS, quit rates at 4 weeks from agreed quit date and 6 months after birth, and birth weight. Outcomes will be analysed by intention to treat, and regression models will be used to compare treatment effects on outcomes. A meta-analysis will include data from the feasibility study in Glasgow. An economic evaluation will assess cost-effectiveness from a UK NHS perspective. Process evaluation using a case-study approach will identify opportunities to improve recruitment and learning for future implementation. Research questions include: what is the therapeutic efficacy of incentives; are incentives cost-effective; and what are the potential facilitators and barriers to implementing incentives in different parts of the UK? DISCUSSION: This phase III trial in Scotland, England and Northern Ireland follows a successful phase II trial in Glasgow, UK. The participating sites have diverse SSS that represent most cessation services in the UK and serve demographically varied populations. If found to be acceptable and cost-effective, this trial could demonstrate that financial incentives are effective and transferable to most UK SSS for pregnant women. TRIAL REGISTRATION: Current Controlled Trials, ISRCTN15236311. Registered on 9 October 2017.
引用
- Sinclair L, McFadden M, Tilbrook H, et al. The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Trials. 2020. PMID: 32059684. doi:10.1186/s13063-019-4042-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。